Correction: Wang et al. Immune Persistence Following a Single Dose of Varicella Vaccine: 5-Year and 8-Year Follow-Up of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial. Vaccines 2025, 13, 1024

Key Points

• To assess the long-term immune persistence following a single dose of the varicella vaccine over a period of five and eight years.
• Conducted a randomized, double-blind, placebo-controlled trial
• Follow-up assessments were made at 5 and 8 years post-vaccination
• Compared immune responses between vaccinated and placebo groups
• Showed sustained immune response at 5 and 8 years post-vaccination
• Indicated no significant difference in immune levels between the study time points
• Emphasized the long-term efficacy of a single-dose vaccination